Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$15.5 - $23.89 $596,750 - $919,765
38,500 Added 37.07%
142,350 $2.6 Million
Q3 2021

Nov 15, 2021

BUY
$17.38 - $21.54 $1.8 Million - $2.24 Million
103,850 New
103,850 $2.11 Million

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Bridger Management, LLC Portfolio

Follow Bridger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridger Management, LLC with notifications on news.